Canada Pension Plan Investment Board lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 301,861 shares of the company's stock after selling 16,554 shares during the quarter. Canada Pension Plan Investment Board owned 0.12% of HCA Healthcare worth $90,604,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently modified their holdings of the company. Whipplewood Advisors LLC purchased a new position in HCA Healthcare during the fourth quarter valued at $31,000. Tidemark LLC bought a new position in HCA Healthcare during the 4th quarter valued at about $36,000. Activest Wealth Management raised its holdings in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after buying an additional 125 shares during the period. Pinnacle Bancorp Inc. boosted its stake in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the period. Finally, Eastern Bank purchased a new position in shares of HCA Healthcare during the fourth quarter worth approximately $62,000. 62.73% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at HCA Healthcare
In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on HCA. KeyCorp decreased their price objective on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. Barclays cut their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. Royal Bank of Canada dropped their target price on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research note on Monday, January 27th. Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $381.67.
Get Our Latest Report on HCA
HCA Healthcare Stock Performance
Shares of HCA Healthcare stock traded up $9.36 on Wednesday, reaching $333.98. 552,541 shares of the stock were exchanged, compared to its average volume of 1,383,336. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The business has a fifty day moving average price of $328.71 and a two-hundred day moving average price of $333.13. The firm has a market capitalization of $82.23 billion, a PE ratio of 15.20, a PEG ratio of 1.10 and a beta of 1.48. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the business posted $5.90 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. HCA Healthcare's dividend payout ratio (DPR) is 13.11%.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.